Watch: YouTuber Strips Down Tesla Model 3 To Find Its Breaking Point

A new Tesla owner and YouTuber dismembered a Model 3 in an attempt to revamp it as a…

A new Tesla owner and YouTuber dismembered a Model 3 in an attempt to revamp it as a different car.

What Happened: In a new video published on the YouTube channel B is for Build, Chris Steinbacher guts a Tesla Model 3 starting with its frunk and doors, to its seats, seatbelts, and bumpers.

“We are going to unbolt every other thing that has a bolt,” says Chris as he embarks on the journey of mutilation to figure out how many parts he can remove before the car stops working.

In the next episode, the YouTuber will run a speed test on the vehicle to see how fast it is without a body and attempt to body-swap the car.

The YouTuber said that he will also attempt to retain the $15,000 autopilot in the Model 3 post-body-swap. “If you ask me to bet on it right now, I don’t think it’s possible. But I’ll try,” he said.

“B is for Build” has 1.62 million subscribers on YouTube. Two weeks ago, the channel posted another video highlighting a safety issue in the Tesla wherein if the battery system in the front of the car were to be damaged in an accident, those in the backseats would not be able to exit the car as their doors would not open.

Check out more of Benzinga’s Future Of Mobility coverage by following this link.

Read More: YouTuber Modifies Tesla Car With 10-Foot Towering Wheels, And Drives It Upside Down

Total
0
Shares
Related Posts
Read More

MorphoSys Shares Higher Premarket After Co Announced on Tuesday an Upfront Payment of $23M from Novartis for Exclusive Worldwide Rights for Pre-clinical Inhibitors of a Novel Cancer Target

MorphoSys announced on Tuesday, that its fully owned subsidiary Constellation Pharmaceuticals, Inc. has entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target. This program was added to MorphoSys' research portfolio following its acquisition of Constellation Pharmaceuticals, Inc.

MOR

Read More

2 High-Yielding Grocery REITs Offer Best ‘Bang For Your Buck’ As A Global Recession Looms

Although the all-items index increased 7.7% for the twelve months ending October, this was the smallest 12-month increase since the period ending January 2022. Meanwhile, food inflation increased by 0.6% in October to 10.9% unadjusted year-over-year.

CVS